Repurposing an FDA-Approved Drug to Inhibit Bacterial Protein Toxins

被引：0
|
作者：
Borho, J. [1 ]
Eckert, A. [1 ]
Koegel, M. [1 ]
Barth, H. [1 ]
机构：
[1] Univ Ulm Med Ctr, Inst Expt & Clin Pharmacol, Toxicol & Pharmacol Nat Prod, Ulm, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2024年 / 397卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P061
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] Repurposing the FDA-approved drug carbidopa to treat human cancers
    Ganapathy, Vadivel
    Babu, Ellappan
    Ramachandran, Sabarish
    Bhutia, Yangzom D.
    CANCER RESEARCH, 2016, 76
  • [2] Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma
    Huq, Sakibul
    Casaos, Joshua
    Serra, Riccardo
    Peters, Michael
    Xia, Yuanxuan
    Ding, Andy S.
    Ehresman, Jeff
    Kedda, Jayanidhi N.
    Morales, Manuel
    Gorelick, Noah L.
    Zhao, Tianna
    Ishida, Wataru
    Perdomo-Pantoja, Alexander
    Cecia, Arba
    Ji, Chenchen
    Suk, Ian
    Sidransky, David
    Brait, Mariana
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1797 - 1808
  • [3] Repurposing the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
    Ding, Andy S.
    Casaos, Joshua
    Huq, Sakibul
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis
    Borho, Joscha
    Koegel, Merle
    Eckert, Amelie
    Barth, Holger
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [5] Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
    Chopra, Sidharth
    Torres-Ortiz, Maria
    Hokama, Leslie
    Madrid, Peter
    Tanga, Mary
    Mortelmans, Kristien
    Kodukula, Krishna
    Galande, Amit K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2598 - 2601
  • [6] Repurposing FDA-approved drugs as potential PARP inhibitors
    Eznarriaga, Maria
    Rahman, Taufiq
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2516 - 2516
  • [7] Repurposing FDA-approved drugs to inhibit IL-33 mediated mast cell function
    Long, Dionna L.
    Burchett, Jason R.
    Ryan, John J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [8] Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials
    Pertusati, Fabrizio
    Pileggi, Elisa
    Richards, Jennifer
    Wootton, Mandy
    Van Leemputte, Thijs
    Persoons, Leentje
    De Coster, David
    Villanueva, Xabier
    Daelemans, Dirk
    Steenackers, Hans
    McGuigan, Christopher
    Serpi, Michaela
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 2864 - 2878
  • [9] Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
    Li, Bin
    Flaveny, Colin A.
    Giambelli, Camilla
    Fei, Dennis Liang
    Han, Lu
    Hang, Brian I.
    Bai, Feng
    Pei, Xin-Hai
    Nose, Vania
    Burlingame, Oname
    Capobianco, Anthony J.
    Orton, Darren
    Lee, Ethan
    Robbins, David J.
    PLOS ONE, 2014, 9 (07):
  • [10] FDA-approved drug promotes remyelination
    Sarah Lempriere
    Nature Reviews Neurology, 2022, 18 : 637 - 637
12345